Sentiss Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENTISS, and what generic and branded alternatives to SENTISS drugs are available?
SENTISS has twelve approved drugs.
Drugs and US Patents for Sentiss
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sentiss Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217195-001 | May 8, 2023 | AT3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sentiss | OFLOXACIN | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 076407-001 | Apr 15, 2008 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sentiss | LOTEPREDNOL ETABONATE | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 215933-001 | Apr 12, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sentiss | LOTEPREDNOL ETABONATE | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 207609-001 | Apr 17, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.